Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer
- 1 August 2001
- Vol. 58 (2) , 240-245
- https://doi.org/10.1016/s0090-4295(01)01114-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genesPublished by Elsevier ,2003
- PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCERJournal of Urology, 2000
- Long-Term Follow-Up of Patients Treated with Intermittent Hormone Therapy for Advanced Prostate CancerThe Prostate Journal, 1999
- The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinomaCancer, 1998
- A pilot study of intermittent androgen deprivation in advanced prostate cancerBritish Journal of Urology, 1998
- Osteoporosis After Orchiectomy for Prostate CancerJournal of Urology, 1997
- Intermittent androgen deprivation after PSA-complete response as a strategy to reduce induction of hormone-resistant prostate cancerUrology, 1997
- Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot studyUrology, 1996
- Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour modelThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Intermittent androgen suppression in the treatment of prostate cancer: A preliminary reportUrology, 1995